Earnings Snapshot: Organon & Co. misses bottom-line estimates; initiates FY26 outlook [Seeking Alpha]
Organon & Co. (OGN)
Company Research
Source: Seeking Alpha
Subscribe to Newsletters Sign Up More on Organon Organon: Deep Value With No Clear Catalysts Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript Organon Non-GAAP EPS of $0.63 misses by $0.10, revenue of $1.51B in-line Organon Q4 Earnings Preview: Cautious view amid weak year Seeking Alpha's Quant Rating on Organon
Show less
Read more
Impact Snapshot
Event Time:
OGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OGN alerts
High impacting Organon & Co. news events
Weekly update
A roundup of the hottest topics
OGN
News
- Organon in charts: Q4 revenue from Women's Health and Established Brands down; Biosimilars up Y/Y [Seeking Alpha]Seeking Alpha
- Organon Reports Results for the Fourth Quarter and Full Year Ended December 31, 2025Business Wire
- Organon & Co. (NYSE:OGN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.MarketBeat
- Organon & Co. (NYSE:OGN) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=OGN&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</aMarketBeat
- Organon To Report Fourth Quarter and Full Year 2025 Results and Host Conference Call on February 12, 2026Business Wire
OGN
Earnings
- 2/12/26 - Miss
OGN
Sec Filings
- 2/12/26 - Form 8-K
- 1/16/26 - Form 4/A
- 11/17/25 - Form 4
- OGN's page on the SEC website